Comparison between Ambey Laboratories IPO and Visaman Global Sales IPO.
IPO Details
Ambey Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Ambey Laboratories IPO is up to ₹42.43 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹15.22 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.
| | Ambey Laboratories IPO | Visaman Global Sales IPO |
|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | |
| Issue Price (Upper) | ₹68.00 per share | |
| Issue Price (Final) | ₹68.00 per share | ₹43.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | | |
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 59,28,000 shares | 35,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹40.31 Cr | up to ₹15.22 Cr |
| OFS Issue Size | 3,12,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹2.12 Cr | up to ₹0.00 Cr |
| Issue Size Total | 62,40,000 shares | 35,40,000 shares |
| Issue Size Total (Amount) | up to ₹42.43 Cr | up to ₹15.22 Cr |
IPO Timetable
Ambey Laboratories IPO opens on Jul 04, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Visaman Global Sales IPO is Jul 08, 2024, and Jun 26, 2024, respectively.
| | Ambey Laboratories IPO | Visaman Global Sales IPO |
|---|
| Anchor Bid Date | Jul 03, 2024 | |
| Issue Open | Jul 04, 2024 | Jun 24, 2024 |
| Issue Close | Jul 08, 2024 | Jun 26, 2024 |
| Basis Of Allotment (Tentative) | Jul 09, 2024 | Jun 27, 2024 |
| Initiation of Refunds (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
| Credit of Share (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
| Listing date (Tentative) | Jul 11, 2024 | Jul 01, 2024 |
| Anchor Lockin End date 1 | Aug 08, 2024 | |
| Anchor Lockin End date 2 | Oct 07, 2024 | |
Financials & KPIs
Ambey Laboratories IPO P/E ratio is 27.81, as compared to Visaman Global Sales IPO P/E ratio of 38.25.
Shares Offered
In the Ambey Laboratories IPO Retail Individual Investors (RII) are offered 21,84,000 shares while in Visaman Global Sales IPO retail investors are offered 21,84,000 shares. Qualified Institutional Buyers (QIB) are offered 12,48,000 shares in Ambey Laboratories IPO and 0 shares in Visaman Global Sales IPO.
| | Ambey Laboratories IPO | Visaman Global Sales IPO |
|---|
| Anchor Investor Reservation | 18,72,000 shares | 0 shares |
| Market Maker Reservation | 3,30,000 shares | 1,92,000 shares |
| QIB | 12,48,000 shares | 0 shares |
| NII | 9,36,000 shares | 17,70,000 shares |
| RII | 21,84,000 shares | 17,70,000 shares |
| Employee | | 0 shares |
| Others | | |
| Total | 62,40,000 shares | 35,40,000 shares |
Bids Received (Subscription)
Ambey Laboratories IPO subscribed 173.18x in total, whereas Visaman Global Sales IPO subscribed 42.20x.
